State Licensing drug reps could regulate sales policies
A ray of hope that might help cleanse medicine of its corrupt interaction with drug company marketers.
A ray of hope that might help cleanse medicine of its corrupt interaction with drug company marketers.
The following confirms to us that the U.S. government (specifically, in this case, the FDA) and licensed academic and/or commercial laboratories that test drugs in human subjects have descended into a moral abyss.
The Journal of Occupational and Environmental Medicine (JOEM) has published a retraction of a 1997 fraudulent article claiming chromium does not cause
cancer.
Two documented news reports provide evidence validating our charge that FDA officials and drug manufacturers.
Informed Consent: The Subject’s Right to Know Here’s what you should ask before you decide to give your informed consent to research. A 1999 report by the Institute of Medicine (IOM), “To Err is Human,” brought to light the magnitude of preventable deaths resulting from medical errors The IOM report…
“There is a crisis of credibility in medicine and science,” says Dr Joseph Sonnabend who, as a former virologist for the Medical Research Council and a retired Aids physician, has watched the basis for public confidence decline.
An investigative report in The Philadelphia Inquirer examined pharmaceutical company ties to six, tax exempt organziations that identify themselves as “patient advocacy” groups, "Each a leading advocate for patients in a disease area.”
Our criticism of a high risk, speculative drug experiment conducted on healthy children and adolescents at Yale University’s Psychiatric Institute was validated by a federal investigation: and our criticism is now validated by the principle investigator, Dr. Thomas McGlashan.
Health Canada has taken constructive step to warn people with high blood pressure, heart disease and other medical ailments NOT to take psychostimulant drugs–which are essentially amphetamines.
The American Psychiatric Association and child psychiatrists in particular are on a collision course:
GSK’s acknowledgement refutes the recent claims made in the official organ of the American Psychiatric Association, The American Journal of Psychiatry.